ArticleImmunity2019
The Immune Landscape of Cancer.
Abstract readPublished Erratum
In one paragraph
Article in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 322 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
322citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
322 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of LPAR1 expression and methylation in low-grade gliomas: a meta-analysis of TCGA and CGGA datasets and functional validation.BMC cancer · 2025Pooled it
- Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.Nature cancer · 2026Trial
- Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Trial
- Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche.Neoplasia (New York, N.Y.) · 2026Article
- Cancer heterogeneity explored through immune cell deconvolution of the tumor microenvironment.Quantitative biology (Beijing, China) · 2026Article
- The Tumor Multi-Omic Landscape of Endometrial Cancers Developed on a Background of Adiposity.Genes · 2026Article
- Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response.Discover oncology · 2026Article
- The expression landscape and clinical significance of cancer-specific RNA transcripts across human cancers.Journal of translational medicine · 2026Article
- Dynamic remodeling of amino acid metabolism in tumor-associated macrophages: Fueling immunosuppression, reshaping tumor niches, and unlocking metabolic checkpoints.Journal of advanced research · 2026Review
- Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated analysis of single-cell and bulk RNA-sequencing.Oncology letters · 2026Article
- Article
- High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer.Annals of surgical oncology · 2026Article
- Immune landscape of gingivo-buccal oral cancer indicates high enrichment of immune-related gene sets in tumors of a large proportion of patients.Molecular medicine (Cambridge, Mass.) · 2026Article
- Unraveling the molecular mechanisms of smoking-associated non-small cell lung cancer: a comprehensive analysis of genetic, therapeutic, and immunological.Journal of thoracic disease · 2026Article
- Ability of lactylation-related genes to stratify patients with ovarian cancer and predict immunotherapy response.Translational cancer research · 2026Article
- Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy.Discover oncology · 2026Article
- Targeting Telomerase in Cancer: Vaccine-Based Strategies, Clinical Evidence, and Synergy with Immunotherapy.Diseases (Basel, Switzerland) · 2026Review
- Harnessing Anoikis-Related Gene Signatures for Immunotherapy Precision: A Machine Learning-Driven Predictive and Prognostic Model.ACS omega · 2026Article
- CHD4 epigenetically coordinates genomic instability and immunosuppression to drive pan-cancer progression and confer HDAC inhibitor sensitivity.Clinical and experimental medicine · 2026Article
- Association of METTL14 expression with prognosis and immunotherapy in breast cancer.Translational cancer research · 2026Article
262 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum for
Authors and funding
58 authors.
Vésteinn ThorssonInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA. Electronic address: vesteinn.thorsson@systemsbiology.org.
David L GibbsInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA.
Scott D BrownCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
Denise WolfUniversity of California, San Francisco, Box 0808, 2340 Sutter Street, S433, San Francisco, CA 94115, USA.
Dante S BortoneLineberger Comprehensive Cancer Center, Curriculum in Bioinformatics and Computational Biology, University of North Carolina, 125 Mason Farm Road, Chapel Hill, NC 27599-7295, USA.
Tai-Hsien Ou YangDepartment of Systems Biology and Department of Electrical Engineering, Columbia University, New York, NY 10027, USA.
Eduard Porta-PardoBarcelona Supercomputing Centre, c/Jordi Girona, 29, 08034 Barcelona, Spain; SBP Medical Discovery Institute, La Jolla, CA 92037, USA.
Galen F GaoThe Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
Christopher L PlaisierInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85281, USA.
James A EddySage Bionetworks, 2901 Third Ave, Suite 330, Seattle, WA 98121, USA.
Elad ZivDepartment of Medicine, Institute for Human Genetics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 1450 3rd St, San Francisco, CA 94143, USA.
Aedin C CulhaneDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Evan O PaullIrving Cancer Research Center, Room 913,1130 St. Nicholas Avenue, New York, NY 10032, USA.
I K Ashok SivakumarDepartment of Computer Science, Institute for Computational Medicine; Johns Hopkins University, Baltimore, MD 21218, USA.
Andrew J GentlesDepartments of Medicine and Biomedical Data Science, Stanford University, Stanford, CA 94305, USA.
Raunaq MalhotraSeven Bridges Genomics, Cambridge, MA 02142, USA.
Farshad FarshidfarDepartment of Oncology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Antonio ColapricoUniversite libre de Bruxelles (ULB), Computer Science Department, Faculty of Sciences, Boulevard du Triomphe - CP212, 1050 Bruxelles, Belgium.
Joel S ParkerLineberger Comprehensive Cancer Center, Curriculum in Bioinformatics and Computational Biology, University of North Carolina, 125 Mason Farm Road, Chapel Hill, NC 27599-7295, USA.
Lisle E MoseLineberger Comprehensive Cancer Center, Curriculum in Bioinformatics and Computational Biology, University of North Carolina, 125 Mason Farm Road, Chapel Hill, NC 27599-7295, USA.
Nam Sy VoDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Jianfang LiuChan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA 15963, USA.
Yuexin LiuDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Janet RaderMedical College of Wisconsin, 9200 Wisconsin Avenue, Milwaukee, WI 53226 USA.
Varsha DhankaniInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA.
Sheila M ReynoldsInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA.
Reanne BowlbyCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
Andrea CalifanoIrving Cancer Research Center, Room 913,1130 St. Nicholas Avenue, New York, NY 10032, USA.
Andrew D CherniackThe Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
Dimitris AnastassiouDepartment of Systems Biology and Department of Electrical Engineering, Columbia University, New York, NY 10027, USA.
Davide BedognettiDivision of Translational Medicine, Research Branch, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar.
Younes MokrabDivision of Translational Medicine, Research Branch, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar.
Aaron M NewmanInstitute for Stem Cell Biology and Regenerative Medicine and Department of Biomedical Data Science, Stanford University, Stanford, CA 94305, USA.
Arvind RaoDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ken ChenDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Alexander KrasnitzSimons Center for Quantitative Biology, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Hai HuChan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA 15963, USA.
Tathiane M MaltaDepartment of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA; Department of Genetics, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Houtan NoushmehrDepartment of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA; Department of Genetics, Ribeirao Preto Medical School, University of São Paulo, São Paulo, Brazil.
Chandra Sekhar PedamalluDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Susan BullmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Akinyemi I OjesinaUniversity of Alabama at Birmingham, Birmingham, AL 35294, USA.
Andrew LambSage Bionetworks, 2901 Third Ave, Suite 330, Seattle, WA 98121, USA.
Wanding ZhouCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Hui ShenCenter for Epigenetics, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Toni K ChoueiriDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
John N WeinsteinDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Justin GuinneySage Bionetworks, 2901 Third Ave, Suite 330, Seattle, WA 98121, USA.
Joel SaltzDepartment of Biomedical Informatics, Stony Brook Medicine, 100 Nicolls Rd, Stony Brook, NY 11794, USA.
Robert A HoltCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
Charles S RabkinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr., Bethesda, MD 20892, USA.
Cancer Genome Atlas Research Network
Alexander J LazarDepartments of Pathology, Genomics Medicine and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd-Unit 85, Houston, TX 77030, USA.
Jonathan S SerodyDepartment of Medicine and Microbiology and Lineberger Comprehensive Cancer Center, 125 Mason Farm Road, Chapel Hill, NC 27599-7295, USA.
Elizabeth G DemiccoMount Sinai Hospital, Department of Pathology and Laboratory Medicine, 600 University Ave., Toronto, ON M5G 1X5, Canada.
Mary L DisisUW Medicine Cancer Vaccine Institute, 850 Republican Street, Brotman Building, 2nd Floor, Room 221, Box 358050, University of Washington, Seattle, WA 98109-4714, USA.
Benjamin G VincentLineberger Comprehensive Cancer Center, Curriculum in Bioinformatics and Computational Biology, University of North Carolina, 125 Mason Farm Road, Chapel Hill, NC 27599-7295, USA. Electronic address: benjamin.vincent@unchealth.unc.edu.
Ilya ShmulevichInstitute for Systems Biology, 401 Terry Ave N, Seattle, WA 98109, USA. Electronic address: ilya.shmulevich@systemsbiology.org.
Funding
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)U24CA210969 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI LAIRD, PETER W · 2016 to 2020
$2.5MTargeted proteomics to aid in the management of patients with stage IA lung adenoR21CA223335 · NCI · RUSH UNIVERSITY MEDICAL CENTER · PI BORGIA, JEFFREY A. · 2018 to 2019
$369kNCI NIH HHS R21 CA223335NCI NIH HHS U24 CA210969
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
31433971What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.